| scholarly article | Q13442814 |
| P50 | author | Ralph H. Hruban | Q21063634 |
| Christine A Iacobuzio-Donahue | Q58327762 | ||
| Anirban Maitra | Q63019787 | ||
| Michael Goggins | Q63021511 | ||
| Volkan Adsay | Q86299315 | ||
| Charles J Yeo | Q96191880 | ||
| Raheela Ashfaq | Q114316683 | ||
| Grace L Shen-Ong | Q114439494 | ||
| Michael A. Hollingsworth | Q115598791 | ||
| P2093 | author name string | Scott E Kern | |
| John L Cameron | |||
| Karin Berg | |||
| P4510 | describes a project that uses | CFPAC-1 | Q28199352 |
| AsPC-1 | Q54750736 | ||
| Capan-1 | Q54808589 | ||
| Capan-2 | Q54808591 | ||
| COLO 357 | Q54814099 | ||
| Hs 766T | Q54896006 | ||
| MIA PaCa-2 | Q54905679 | ||
| Panc 02.13 | Q54937515 | ||
| Panc 03.27 | Q54937517 | ||
| Panc 04.14 | Q54937521 | ||
| Panc 06.03 | Q54937527 | ||
| Panc 08.13 | Q54937528 | ||
| PANC-1 | Q54937550 | ||
| PL4 | Q54947521 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| cell line | Q21014462 | ||
| P304 | page(s) | 8614-8622 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies | |
| P478 | volume | 63 |
| Q33388611 | 14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness |
| Q41985946 | A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study |
| Q90134538 | A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas |
| Q31147681 | A comparative analysis of transcript abundance using SAGE and Affymetrix arrays |
| Q37217296 | A comparison of global gene expression measurement technologies in Arabidopsis thaliana |
| Q33992146 | A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma |
| Q36640803 | AGR2 is associated with gastric cancer progression and poor survival |
| Q89077427 | Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer |
| Q33693132 | Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues |
| Q37263038 | Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors |
| Q41859754 | Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer |
| Q28834154 | Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers |
| Q33859857 | CA125 in ovarian cancer |
| Q35017547 | CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture |
| Q24791193 | Characterization of human mesothelin transcripts in ovarian and pancreatic cancer |
| Q36965062 | Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma |
| Q33287052 | Comparison of hybridization-based and sequencing-based gene expression technologies on biological replicates. |
| Q41903918 | Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. |
| Q41334598 | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression |
| Q42053166 | CpG island methylation profile of pancreatic intraepithelial neoplasia |
| Q34300716 | Cross-platform Comparison of Two Pancreatic Cancer Phenotypes |
| Q41916266 | DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease |
| Q27851466 | DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. |
| Q31031668 | Deciphering c-MYC-regulated genes in two distinct tissues. |
| Q40034316 | Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry |
| Q24813357 | Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers |
| Q33925226 | Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer |
| Q35152011 | Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma |
| Q36730571 | ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells |
| Q36667422 | Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia |
| Q34119094 | Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers |
| Q28485145 | Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system |
| Q35892368 | Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer. |
| Q89579545 | Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer |
| Q24813318 | Evaluation of the similarity of gene expression data estimated with SAGE and Affymetrix GeneChips |
| Q24337345 | Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer |
| Q36640466 | Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia |
| Q47182822 | Expression signatures of early-stage and advanced medaka melanomas |
| Q34134515 | Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. |
| Q35555679 | Fascin promotes the motility and invasiveness of pancreatic cancer cells |
| Q33425930 | Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells |
| Q36920133 | Flap endonuclease 1. |
| Q35294688 | Further characterization of HDAC and SIRT gene expression patterns in pancreatic cancer and their relation to disease outcome |
| Q30620697 | Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation |
| Q40795286 | Gene expression profiles associated with advanced pancreatic cancer. |
| Q36610590 | Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model |
| Q34928555 | Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays |
| Q34589293 | Genetics and pathology of pancreatic cancer |
| Q36184419 | Genomics of pancreatic cancer: does it make any improvement in diagnosis, prognosis and therapy? |
| Q42147260 | Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer |
| Q35207321 | Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome |
| Q36326330 | Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas |
| Q41038023 | Identification of TMPRSS3 as a Significant Contributor to Autosomal Recessive Hearing Loss in the Chinese Population. |
| Q40273975 | Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples |
| Q36623404 | Identification of cancer genomic markers via integrative sparse boosting |
| Q38450835 | Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses |
| Q36609719 | Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation. |
| Q37376186 | Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS. |
| Q36328508 | Identifying molecular markers for the early detection of pancreatic neoplasia |
| Q47903216 | Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody |
| Q58779449 | Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker |
| Q39131965 | Induction and translocation of tissue transglutaminase isoforms increased phosphorylation in retinoic acid treated erythroleukemia cells |
| Q34224746 | Inhibition of mesothelin as a novel strategy for targeting cancer cells |
| Q33849612 | Integrative analysis and variable selection with multiple high-dimensional data sets |
| Q58711412 | Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas |
| Q31072766 | Integrative prescreening in analysis of multiple cancer genomic studies |
| Q36015267 | Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells |
| Q39433508 | Key contribution of CPEB4-mediated translational control to cancer progression |
| Q36054255 | Lipocalin 2: a multifaceted modulator of human cancer |
| Q28484227 | Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma |
| Q41764233 | MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. |
| Q36645343 | Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology |
| Q37044754 | Mesothelin expression is a prognostic factor in cholangiocellular carcinoma |
| Q24622837 | Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer |
| Q24642374 | Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy |
| Q33735285 | Mesothelin promotes cell proliferation in the remodeling of neonatal rat pancreas |
| Q36787043 | Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells |
| Q34571373 | Molecular analysis of precursor lesions in familial pancreatic cancer |
| Q36485336 | Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts |
| Q36829524 | Molecular genetics of pancreatic intraepithelial neoplasia |
| Q36438761 | Molecular markers associated with outcome and metastasis in human pancreatic cancer. |
| Q37081461 | Molecular markers of pancreatic cancer: development and clinical relevance |
| Q34008627 | Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas |
| Q36437150 | Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. |
| Q38166583 | Mucins and pancreatic cancer. |
| Q36896764 | Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer |
| Q34890054 | Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells |
| Q39954411 | Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer |
| Q30489770 | New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. |
| Q37637310 | Novel Mutations and Mutation Combinations of TMPRSS3 Cause Various Phenotypes in One Chinese Family with Autosomal Recessive Hearing Impairment |
| Q38671234 | Pancreatic Cancer: Clinical Significance of Biomarkers |
| Q34616999 | Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells |
| Q35176601 | Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function. |
| Q30490247 | Pancreatic cancer. |
| Q37125627 | Pancreatic carcinogenesis |
| Q34560967 | Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas |
| Q35111396 | Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma |
| Q36109481 | Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma |
| Q34302430 | Phenotypic analysis of mice lacking the Tmprss2-encoded protease |
| Q41859957 | Poly(A) RT-PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer |
| Q54963213 | Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. |
| Q35738659 | Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma |
| Q86155796 | Prognostic value of TMPRSS4 expression in patients with breast cancer |
| Q35811508 | Protease-activated drug development |
| Q52666355 | Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges. |
| Q80305915 | Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins |
| Q93167444 | Pseudostellaria heterophylla Extract Polysaccharide H-1-2 Suppresses Pancreatic Cancer by Inhibiting Hypoxia-Induced AG2 |
| Q84463291 | RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression |
| Q42335704 | RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer |
| Q37139815 | Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival |
| Q33396835 | Regularized gene selection in cancer microarray meta-analysis |
| Q33929696 | Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer |
| Q35585043 | Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis. |
| Q35153678 | Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter |
| Q48489222 | Statistical validation of two sample comparison methods for oligonucleotide microarray in rat ischemia model |
| Q37338222 | Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo |
| Q38774630 | Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract |
| Q35854198 | TMPRSS3 is a novel poor prognostic factor for breast cancer |
| Q35087555 | TRIM29 suppresses TWIST1 and invasive breast cancer behavior. |
| Q36685675 | Target discovery and validation in pancreatic cancer |
| Q52333009 | Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. |
| Q33735020 | Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. |
| Q37182283 | The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target |
| Q38751339 | The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia |
| Q38276382 | The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma |
| Q38238094 | The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics |
| Q52587886 | The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. |
| Q36614617 | The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines |
| Q24528155 | The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells |
| Q34365135 | The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma |
| Q38206321 | The cutting edges in DNA repair, licensing, and fidelity: DNA and RNA repair nucleases sculpt DNA to measure twice, cut once |
| Q36912649 | The differentiation of pancreatic tumor-initiating cells by vitronectin can be blocked by cilengitide |
| Q34181948 | The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma |
| Q37153303 | The molecular biology of pancreatic cancer |
| Q55483367 | Therapeutic antibodies for the treatment of pancreatic cancer. |
| Q38161340 | Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer |
| Q28478758 | Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer |
| Q38311664 | Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer |
| Q39945610 | Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation |
| Q36916874 | Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling |
| Q37514770 | Tissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/β-catenin signaling |
| Q36503511 | Tissue transglutaminase: a new target to reverse cancer drug resistance |
| Q38314502 | Transcriptional regulation of human MUC4 gene: identification of a novel inhibitory element and its nuclear binding protein |
| Q33400860 | Transcriptomic and proteomic profiling of two porcine tissues using high-throughput technologies |
| Q28069852 | Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death |
| Q38648421 | Transglutaminase 2 in cancer |
| Q93188555 | Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations |
| Q26799862 | Transglutaminase is a tumor cell and cancer stem cell survival factor |
| Q46537237 | Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells |
| Q33710081 | Urinary kallikrein 10 predicts the incurability of gastric cancer |
| Q34354775 | Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer |
| Q35189855 | Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
| Q47093762 | mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival |
Search more.